CTCX
Price
$0.24
Change
-$0.00 (-0.00%)
Updated
Feb 21 closing price
Capitalization
7.22M
URGN
Price
$10.08
Change
-$0.63 (-5.88%)
Updated
Feb 21 closing price
Capitalization
425.37M
19 days until earnings call
Ad is loading...

CTCX vs URGN

Header iconCTCX vs URGN Comparison
Open Charts CTCX vs URGNBanner chart's image
Carmell
Price$0.24
Change-$0.00 (-0.00%)
Volume$152.63K
Capitalization7.22M
UroGen Pharma
Price$10.08
Change-$0.63 (-5.88%)
Volume$801.78K
Capitalization425.37M
CTCX vs URGN Comparison Chart
Loading...
CTCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTCX vs. URGN commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTCX is a Hold and URGN is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (CTCX: $0.24 vs. URGN: $10.71)
Brand notoriety: CTCX and URGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTCX: 1% vs. URGN: 57%
Market capitalization -- CTCX: $7.22M vs. URGN: $425.37M
CTCX [@Biotechnology] is valued at $7.22M. URGN’s [@Biotechnology] market capitalization is $425.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTCX’s FA Score shows that 0 FA rating(s) are green whileURGN’s FA Score has 0 green FA rating(s).

  • CTCX’s FA Score: 0 green, 5 red.
  • URGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both CTCX and URGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTCX’s TA Score shows that 4 TA indicator(s) are bullish while URGN’s TA Score has 5 bullish TA indicator(s).

  • CTCX’s TA Score: 4 bullish, 6 bearish.
  • URGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, URGN is a better buy in the short-term than CTCX.

Price Growth

CTCX (@Biotechnology) experienced а -0.46% price change this week, while URGN (@Biotechnology) price change was +1.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +3.87%, and the average quarterly price growth was +3.11%.

Reported Earning Dates

CTCX is expected to report earnings on Mar 17, 2023.

URGN is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
URGN($425M) has a higher market cap than CTCX($7.22M). URGN YTD gains are higher at: 0.563 vs. CTCX (-14.403). CTCX has higher annual earnings (EBITDA): -9.47M vs. URGN (-97.82M). URGN has more cash in the bank: 250M vs. CTCX (1.14M). CTCX has less debt than URGN: CTCX (782K) vs URGN (122M). URGN has higher revenues than CTCX: URGN (89.4M) vs CTCX (32.8K).
CTCXURGNCTCX / URGN
Capitalization7.22M425M2%
EBITDA-9.47M-97.82M10%
Gain YTD-14.4030.563-2,557%
P/E Ratio0.50N/A-
Revenue32.8K89.4M0%
Total Cash1.14M250M0%
Total Debt782K122M1%
FUNDAMENTALS RATINGS
URGN: Fundamental Ratings
URGN
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTCXURGN
RSI
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
37%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
45%
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
61%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 17 days ago
51%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
Bearish Trend 16 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Ad is loading...
CTCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEBIX13.780.06
+0.44%
First Eagle Global Income Builder I
HDQVX16.580.07
+0.42%
Janus Henderson Responsible Intl DivS
DHTYX24.440.03
+0.12%
Diamond Hill Select Y
NQCAX5.17N/A
N/A
Nuveen Large Cap Value Opportunities A
PAGSX66.11N/A
N/A
T. Rowe Price Global Stock Adv

CTCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTCX has been loosely correlated with RAIN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CTCX jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTCX
1D Price
Change %
CTCX100%
-2.73%
RAIN - CTCX
53%
Loosely correlated
+1.25%
ATNF - CTCX
35%
Loosely correlated
N/A
PRQR - CTCX
28%
Poorly correlated
-2.64%
URGN - CTCX
25%
Poorly correlated
-1.02%
EYEN - CTCX
25%
Poorly correlated
-4.95%
More